Nucleic acid-based non-invasive prenatal diagnosis of genetic skin diseases: Are we ready?

5Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The discovery of circulating fetal nucleic acids is a great step on the way of developing non-invasive prenatal diagnosis (NIPD) for genetic disorders. Here, we briefly discuss the current applications of circulating fetal nucleic acids in genetic testing for different kinds of hereditary diseases with an emphasis on using circulating cell-free fetal DNA in diagnosis of monogenic disorders. As the genetic skin disorders impair the quality of life at different levels, we next discuss some ethical issues in NIPD for genetic skin diseases of various severities and in particular, the responsibility of doctors and parents, respectively, in the prenatal genetic testing. © 2013 John Wiley & Sons A/S.

Cite

CITATION STYLE

APA

Ma, Y., Gong, H., & Wen, Y. (2013). Nucleic acid-based non-invasive prenatal diagnosis of genetic skin diseases: Are we ready? Experimental Dermatology, 22(6), 392–395. https://doi.org/10.1111/exd.12156

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free